tiprankstipranks
Trending News
More News >
Genor Biopharma Holdings Limited (DE:67N0)
FRANKFURT:67N0
Germany Market

Genor Biopharma Holdings Limited (67N0) Income Statement

Compare
0 Followers

Genor Biopharma Holdings Limited Income Statement

Last quarter (Q4 2024), Genor Biopharma Holdings Limited's total revenue was ¥95.88M, an increase of Infinity% from the same quarter last year. In Q4, Genor Biopharma Holdings Limited's net income was ¥37.21M. See Genor Biopharma Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 206.23M¥ 0.00¥ 15.93M¥ 0.00¥ 10.33M
Gross Profit
¥ 204.89M¥ 0.00¥ 14.95M¥ 0.00¥ 7.74M
Operating Expenses
¥ 277.44M¥ 711.20M¥ 801.15M¥ 899.51M¥ 932.16M
Depreciation and Amortization
¥ 65.28M¥ 65.28M¥ 53.68M¥ 44.01M¥ 50.48M
EBITDA
¥ -5.15M¥ -551.01M¥ -675.89M¥ -819.50M¥ -2.98B
Operating Income
¥ -72.55M¥ -711.20M¥ -786.21M¥ -859.11M¥ -924.42M
Other Income/Expenses
¥ 37.42M¥ 33.70M¥ 50.30M¥ -7.20M¥ -133.29M
Pretax Income
¥ -35.13M¥ -677.50M¥ -732.42M¥ -866.31M¥ -3.04B
Net Income
¥ -51.28M¥ -674.36M¥ -730.40M¥ -865.37M¥ -3.03B
Per Share Metrics
Basic EPS
¥ -0.10¥ -1.33¥ -1.45¥ -1.75¥ -12.37
Diluted EPS
¥ -0.10¥ -1.33¥ -1.45¥ -1.74¥ -12.37
Weighted Average Shares Outstanding
513.55M 506.25M 504.30M 495.18M 244.89M
Weighted Average Shares Outstanding (Diluted)
513.55M 506.25M 504.81M 496.20M 244.89M
Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis